Hae Su Kim

739 total citations
26 papers, 511 citations indexed

About

Hae Su Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Hae Su Kim has authored 26 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Neurology. Recurrent topics in Hae Su Kim's work include Lung Cancer Treatments and Mutations (3 papers), Myasthenia Gravis and Thymoma (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Hae Su Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Myasthenia Gravis and Thymoma (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Hae Su Kim collaborates with scholars based in South Korea. Hae Su Kim's co-authors include Sung Hee Lim, Ji Yun Lee, Keunchil Park, Jong‐Mu Sun, Myung‐Ju Ahn, Se‐Hoon Lee, Jin Seok Ahn, Young Hyeh Ko, Haa‐Na Song and Ki Sun Jung and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Hae Su Kim

25 papers receiving 503 citations

Peers

Hae Su Kim
E. Joosens Belgium
Ramón Palmero Spain
Junichi Tomomatsu Japan
Tetsuya Urasaki Japan
Virginia Arrazubi Spain
Prakash Peddi United States
Boyang Chang China
Lawrence Garbo United States
Ryo Toyozawa Japan
E. Joosens Belgium
Hae Su Kim
Citations per year, relative to Hae Su Kim Hae Su Kim (= 1×) peers E. Joosens

Countries citing papers authored by Hae Su Kim

Since Specialization
Citations

This map shows the geographic impact of Hae Su Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hae Su Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hae Su Kim more than expected).

Fields of papers citing papers by Hae Su Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hae Su Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hae Su Kim. The network helps show where Hae Su Kim may publish in the future.

Co-authorship network of co-authors of Hae Su Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hae Su Kim. A scholar is included among the top collaborators of Hae Su Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hae Su Kim. Hae Su Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jung, Hyun Ae, Miso Kim, Hae Su Kim, et al.. (2022). A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21). Journal of Thoracic Oncology. 18(2). 223–231. 16 indexed citations
4.
Kim, Hae Su, Ji Yun Lee, Su Jin Lee, et al.. (2017). A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer. BMC Urology. 17(1). 63–63. 8 indexed citations
5.
Kim, Hae Su, Hee‐Jin Kim, Sun‐Hee Kim, et al.. (2017). Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea. The Korean Journal of Internal Medicine. 32(5). 890–899. 14 indexed citations
6.
Kim, Hae Su, Kyung Ju Ryu, Young Hyeh Ko, et al.. (2016). Macrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma. Hematological Oncology. 35(3). 310–316. 14 indexed citations
7.
Lee, Min‐Young, Bo Mi Ku, Hae Su Kim, et al.. (2016). Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer. Cancer Research and Treatment. 49(4). 906–914. 21 indexed citations
8.
Kim, Hae Su, Jin Seok Heo, Jeeyun Lee, et al.. (2016). The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis. BMC Cancer. 16(1). 120–120. 41 indexed citations
9.
Lee, Ji Yun, Sung Hee Lim, Min‐Young Lee, et al.. (2016). The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC). PLoS ONE. 11(2). e0149432–e0149432. 3 indexed citations
10.
Kim, Hae Su, Ji Yun Lee, Sung Hee Lim, et al.. (2016). Assessment of objective responses in thymic epithelial tumors using ITMIG modified criteria. Lung Cancer. 96. 48–51. 2 indexed citations
11.
Kim, Hee Kyung, Seonggyu Byeon, Kwai Han Yoo, et al.. (2016). Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea. Cancer Research and Treatment. 48(4). 1382–1388. 9 indexed citations
12.
Lee, Ji Yun, Won Jin Chang, Sung Hee Lim, et al.. (2016). MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. Oncotarget. 7(28). 43492–43503. 48 indexed citations
13.
Kim, Hae Su, Ji Yun Lee, Sung Hee Lim, et al.. (2016). Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma. Nutrition. 36. 67–71. 23 indexed citations
14.
Moon, Seung Hwan, Hae Su Kim, Young Seok Cho, et al.. (2016). Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor. Lung Cancer. 100. 24–29. 7 indexed citations
15.
Lee, Ji Yun, Jong‐Mu Sun, Sung Hee Lim, et al.. (2015). A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non–Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib. Clinical Cancer Research. 22(9). 2139–2145. 28 indexed citations
16.
Song, Haa‐Na, Ki Sun Jung, Kwai Han Yoo, et al.. (2015). Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 11(4). e45–e47. 92 indexed citations
17.
Kim, Hae Su, Ji Yun Lee, Sung Hee Lim, et al.. (2015). A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors. Journal of Thoracic Oncology. 10(12). 1800–1806. 29 indexed citations
18.
Kim, Hae Su, Seonggyu Byeon, Hee Kyung Kim, et al.. (2015). The prevalence and prognostic relevance of PD-L1 expression in patients with HPV-negative and HPV-positive oropharyngeal cancer.. Journal of Clinical Oncology. 33(15_suppl). e14003–e14003. 2 indexed citations
19.
Sohn, Joo Hyun, et al.. (2014). Long-term Successful Treatment of Massive Distal Duodenal Variceal Bleeding with Balloon-occluded Retrograde Transvenous Obliteration. Korean Journal of Gastroenterology. 63(4). 248–248. 7 indexed citations
20.
Lee, Jong Min, et al.. (2002). A Case of Congenital Nephrogenic Diabetes Insipidus with Bilateral Hydronephrosis and Hydroureter.. 21(6). 1026–1031. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Joosens Breakdown of academic impact, for papers by Ramón Palmero Breakdown of academic impact, for papers by Junichi Tomomatsu Breakdown of academic impact, for papers by Tetsuya Urasaki Breakdown of academic impact, for papers by Virginia Arrazubi Breakdown of academic impact, for papers by Prakash Peddi Breakdown of academic impact, for papers by Boyang Chang Breakdown of academic impact, for papers by Lawrence Garbo Breakdown of academic impact, for papers by Ryo Toyozawa
Rankless by CCL
2026